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Ras proteins function as signaling hubs that are acti-
vated by convergent signaling pathways initiated by
extracellular stimuli. Activated Ras in turn regulates a
diversity of downstream cytoplasmic signaling cas-
cades. Ras proteins are founding members of a large
superfamily of small GTPases that have significant
sequence and biochemical similarities. Recent obser-
vations have established a complex signaling inter-
play between Ras and other members of the family. A
key biochemical mechanism facilitating this crosstalk
involves guanine nucleotide exchange factors (GEFs),
which serve as regulators and effectors, as well as
signaling integrators, of Ras signaling.
Introduction
The three human Ras proteins — H-Ras, N-Ras, K-
Ras — function as regulated GDP/GTP molecular
switches that control diverse signaling networks
important for the regulation of cell proliferation, sur-
vival, differentiation, actin organization, vesicular traf-
ficking, and gene expression. Guanine nucleotide
exchange factors (GEFs) stimulate the intrinsic
GDP/GTP exchange activity of Ras and promote for-
mation of active Ras–GTP, whereas GTPase-activat-
ing proteins (GAPs) stimulate the slow intrinsic GTP
hydrolysis activity of Ras to promote formation of
inactive Ras–GDP (Figure 1). The structural differences
between the GDP- and GTP-bound states of Ras are
localized to two regions of the protein, termed switch
I (Ras residues 32–38) and switch II (residues 59–67),
with the GTP-bound conformation exhibiting
increased affinity for downstream effectors.
Ras proteins are the founding members of a large
superfamily of small GTPases composed of ~150
human members [1]. Based on sequence and func-
tional similarities, the family is divided into at least five
distinct branches: Ras, Rho, Rab, Arf, and Ran.
Members of the Ras branch, comprising 36 human
members, represent those with greatest amino acid
sequence similarity (up to 55%) and functional simi-
larity with Ras and include R-Ras, Ral, and Rap pro-
teins. Ras GEFs and GAPs can also regulate the
GDP/GTP cycling of other members of the Ras super-
family. In contrast, the GDP/GTP cycle of members of
the Rho branch (20 human members) is regulated by
distinct Rho-specific GEFs and GAPs. Like Ras,
however, Rho GTPases also function as signaling
hubs that are activated by many of the same extracel-
lular stimuli that activate Ras. In addition to these bio-
chemical and functional relationships, Ras is also a
component of signaling networks involving other Ras
superfamily proteins. Critical elements that facilitate
GTPase cascades and crosstalk are GEFs. In this
review, we provide an update on the expanding roster
of the GEFs, GAPs, and effectors that regulate and
mediate Ras activity. In particular, we highlight some
of the GEF-mediated mechanisms that link the func-
tion of Ras with its relatives in the family.
RasGEFs Facilitate Signaling Convergence and
Divergence
All RasGEFs have a common ~250 amino acid CDC25
homology catalytic domain (also called the RasGEF
domain) and an adjacent ~50 amino acid amino-termi-
nal Ras exchange motif (REM; also called the
RasGEFN domain) [2]. The three main classes of
RasGEFs (Sos, Ras-GRF, and RasGRP) are distin-
guished by additional flanking domains and motifs
that facilitate their activation by distinct upstream sig-
naling mechanisms or possess additional catalytic
functions (Figure 2A). The ability of the CDC25 homol-
ogy domains to concurrently activate other Ras family
proteins and the presence of separate Rho-specific
GEF catalytic domains in Sos and Ras-GRF proteins
provide links between Ras activation and the function
of Ras and Rho family proteins.
Sos and Ras-GRFs Are Dual-Specificity Exchange
Factors for Ras and Rac
The two main RasGEF families, Sos and Ras-GRF,
also serve as GEFs for the Rac small GTPase, a
member of the Rho branch of the Ras superfamily [3].
Sos1 and Sos2 contain a CDC25 homology domain
which acts as a GEF for Ras as well as R-Ras2 and R-
Ras3 proteins (Table 1). In addition to the CDC25
homology domain, the amino termini of Sos proteins
contain Dbl homology (DH; also called RhoGEF) and
pleckstrin homology (PH) domains (Figure 2A). The
tandem DH–PH domain cluster is a signature motif of
Dbl family proteins, which comprise the majority of
GEFs for Rho family GTPases [4]. The catalytic DH
domain mediates the GDP/GTP exchange on Rho
GTPases, while the PH domain modulates the activity
of the DH domain by a variety of mechanisms, for
example by promoting membrane association, facili-
tating GTPase substrate binding, or by controlling
intramolecular interactions. Thus, Sos proteins are
endowed with a dual GEF catalytic activity for Ras and
Rac GTPases.
The mechanisms of receptor tyrosine kinase medi-
ated Sos-dependent activation of Ras are well char-
acterized [2]. In resting cells, Sos1 is stably
associated with the Src homology 3 (SH3) domains of
the Grb2 adaptor protein (Figure 3). Upon receptor
stimulation, the Grb2–Sos complex is recruited to the
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plasma membrane by the association of the Grb2
SH2 domain with specific autophosphorylated tyro-
sine residues in the carboxy-terminal cytoplasmic
domain of the activated receptor. This binding pro-
motes the translocation of the cytosolic Grb2–Sos1
complex to the plasma membrane, and positions it in
direct proximity to membrane-bound Ras, thus allow-
ing for activation of Ras. Other mechanisms of Ras
activation also utilize the Grb2–Sos complex. For
example, Gαi- and Gαq-linked G protein-coupled
receptor upregulation of Ca2+ causes activation of the
PYK2 tyrosine kinase, which then binds to and acti-
vates the Src tyrosine kinase (Figure 3). Src phos-
phorylation of PYK2 promotes Grb2–Sos association
with PYK2 and Ras activation [5].
Distinct mechanisms have been found to stimulate
Sos-mediated activation of Rac. Phospholipids regu-
lated by phosphatidylinositol 3-kinase (PI3K) may
interact with the PH domain of Sos to regulate
allosteric control of the DH domain GEF activity [6]
(Figure 3). The association of the PI3K substrate phos-
phatidylinositol 4,5-bisphosphate (PIP2) with the PH
domain promotes an intramolecular autoinhibitory
interaction between the PH and DH domains of Sos,
whereas the binding of the PI3K product phos-
phatidylinositol 3,4,5-trisphosphate (PIP3) relieves this
intramolecular autoinhibition [7].
A second mechanism that stimulates Sos activation
of Rac involves the formation of the trimeric complex
of Sos, Eps8, and Abi-1 (also called E3b1) [8] (Figure
3). Eps8 is tyrosine phosphorylated by receptor tyro-
sine kinases and, through its SH3 domain, associates
with Abi-1, an SH3-domain-containing protein
involved in regulation of actin organization. The
Eps8–Abi-1 complex, through the Abi-1 SH3 domain,
associates with the proline-rich carboxyl terminus of
Sos1. Since this proline-rich region of Sos1 coincides
with the binding site for the SH3 domains of Grb2, the
association of Grb2 and Eps8–Abi-1 with Sos1 is
mutually exclusive [9] (Figure 3). Sos–Abi-1–Eps8
complexes isolated from cells were active only on
Rac, whereas Grb2–Sos complexes possessed
exchange activity only toward Ras [10]. The RacGEF
activity of the Sos–Abi-1–Eps8 complex was depen-
dent on PI3K binding, via a direct interaction of Abi-1
with the p85 regulatory subunit of PI3K. Finally,
recent evidence suggests that epidermal growth
factor receptor (EGFR)-mediated activation of Abl
and Abl tyrosine phosphorylation of Sos are sufficient
for activation of the RacGEF activity of Sos in vitro
and in vivo [11].
As described above, the distinct mechanisms of
regulation and activation of Sos may promote tempo-
rally and spatially distinct modes of activation of Ras
and Rac. Grb2–Sos-dependent activation of Ras
downstream of receptor tyrosine kinases was found to
occur transiently at the plasma membrane [9],
whereas Rac activation downstream of receptor tyro-
sine kinases was sustained and occurred at the sites
of plasma membrane ruffling.
Interestingly, recent structural studies demon-
strated that Ras itself can regulate the RasGEF activ-
ity of Sos1 (Figure 3). Kuriyan, Bar-Sagi and
colleagues [12] showed that Ras can bind to a distal,
allosteric site in Sos1 upstream of the CDC25 homol-
ogy domain. Binding of Ras–GDP to this site con-
verted Sos1 to a low level of activity, whereas
Ras–GTP binding at this site promoted higher Sos1
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Figure 1. Regulation of the Ras GDP/GTP
cycle.
The structural differences between the
GDP-bound and GTP-bound (PDB: 4Q21
and 5P21, respectively) states of Ras
(green) are localized to two regions of the
protein (red), termed switch I (Ras
residues 32–38) and switch II (residues
59–67), with the GTP-bound conformation
exhibiting increased affinity for down-
stream effectors. The structure of
nucleotide-free human H-Ras (residues
1–166) in complex with the catalytic Ras-
binding domain of human Sos1 (residues
564–1049; PDB: 1BKD) includes the REM
(blue) and CDC25 (yellow) homology
domain. The structure of H-Ras–GDP
(residues 1–166) in the presence of alu-
minum fluoride is shown in complex with
the catalytic RasGAP fragment of human
p120 RasGAP (residues 1198–1530), with
interaction predominantly with switch I
and II (PDB: 1WQ1) [100]. The structure of
H-Ras (residues 1–166) bound with the
GTP-hydrolysis-resistant GTP analog
GppNHp, is shown in complex with the 97
amino acid RA domain of human RalGDS
(residues 790-886; PDB: 1LFD) [101].
activity and faster nucleotide exchange on Ras–GDP
bound at the catalytic site [13]. Finally, the DH domain
also influences the RasGEF activity of the adjacent
CDC25 homology domain. Structural analysis of a
fragment of Sos1 comprising the DH, PH, REM, and
CDC25 homology domains determined that the DH
domain was positioned to prevent Ras association
with the allosteric binding site (Figure 3). How the neg-
ative autoregulatory function of the DH domain is
relieved to promote RasGEF activity has not yet been
determined.
Similar to Sos, Ras-GRFs also possess tandem
REM–CDC25 and DH–PH domains (Figure 2A). Ras-
GRFs act on Ras as well as R-Ras proteins (Table 1).
The RasGEF activity of Ras-GRF is stimulated by
Ca2+-dependent calmodulin association with the IQ
motif [14] (Figure 4). Interestingly, the calcium-stimu-
lated RasGEF activity of Ras-GRF1 appeared to be
dependent on intact DH and PH domains in vivo, but
not in vitro [15]. In contrast to Grb2-mediated activa-
tion of Sos1, Ca2+ stimulation and calmodulin associ-
ation with Ras-GRF1 or Ras-GRF2 did not cause
increased GEF association with the plasma mem-
brane nor did it alter the intrinsic RasGEF activity of
Ras-GRF1. Instead, Ras-GRF1 appears to be consti-
tutively associated with the membrane. In contrast,
Ras-GRF2 activation by Ca2+ was found to correlate
with its translocation from the cytosol to the cellular
periphery [16].
Whereas activation of receptor tyrosine kinases
utilizes Sos-dependent mechanisms for Ras activa-
tion, this activation typically does not involve Ras-
GRF. Instead, under physiological conditions
Ras-GRF promotes Ras activation downstream of N-
methyl-D-aspartate glutamate ligand-gated ion
channel receptors (NMDARs) [17]. Studies in grf1-
and grf2-deficient mice revealed that both Ras-GRF1
and Ras-GRF2 function to couple NMDARs to the
activation of the Ras/Erk MAP kinase signaling
cascade in cortical neurons of adult mice. This
involves receptor-stimulated Ca2+ influx and direct
association of the receptor with Ras-GRF1 [18].
Interestingly, in neonatal animals NMDAR signaling
to the Ras/Erk cascade appears to be mediated by
Sos rather than Ras-GRF [17].
Similar to Sos, Ras-GRF1 and Ras-GRF2 also
possess DH-domain-dependent RacGEF activity
[19–21]. Additionally, distinct mechanisms have been
found to preferentially activate the RasGEF and
RacGEF activities of Ras-GRF. For example, Gβγ-
mediated activation of Ras-GRF1 stimulated tyrosine
phosphorylation-dependent activation of its RacGEF,
but not RasGEF, activity [20]. This activation may
involve activation of Src and Src-mediated phospho-
rylation of Ras-GRF1 [21] (Figure 4), although tyro-
sine phosphorylation of endogenous Ras-GRF1 in
neurons has not yet been shown. In contrast, tyro-
sine phosphorylation of Ras-GRF1 mediated by the
non-receptor tyrosine kinase ACK1 stimulated
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Figure 2. Ras regulators and effectors.
(A) RasGEFs. In addition to the CDC25 domain, Sos and Ras-
GRF contain DH RhoGEF and PH domains. Other domains found
in RasGEFs include: H2A, histone 2A homology; IQ, short
calmodulin-binding motif containing conserved I and Q residues;
EF, Ca2+-binding EF hand; and C1, protein kinase C conserved
region 1, which binds DAG and phorbol esters. (B) RasGAPs.
RasGAPs have a common ~250 amino acid α-helical catalytic
domain (RasGAP). Other domains present in RasGAPs include:
SH2, Src homology 2; SH3, Src homology 3; PH; C2, protein
kinase C conserved region 2 that serves as a Ca2+-dependent
lipid-binding motif; Sec14, Sec14p-like lipid-binding domain; and
BTK, Bruton’s tyrosine kinase cysteine-rich zinc-binding motif.
(C) Ras effectors with GEF catalytic domains. All RalGEFs
contain a REM and a CDC25 homology domain. PLCε also con-
tains a CDC25 homology domain, but lacks a clear REM domain.
Additionally, PLCε contains a PH domain, EF hand Ca2+-binding
motifs, the phospholipase C X and Y catalytic boxes (PLCX and
PLCY) and a C2 domain. In addition to the tandem DH–PH
domain structure characteristic of RhoGEFs, Tiam1 contains the
Raf-like RBD, a second PH domain, and a PDZ domain. In addi-
tion to an RA domain, RIN family proteins also possess an SH2
domain. The domain architecture of Ras-interacting proteins was
generated by using SMART (http://smart.embl-heidelberg.de/).
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RasGEF, but not RacGEF, activity [22] (Figure 4). The
specific tyrosine residues phosphorylated by each
kinase, and how these events regulate Ras-GRF1
activity, are not known.
RasGRPs: Mediators of Second Messenger
Activation of Ras
The four RasGRP members (also called CalDAG-
GEFs) constitute a group of RasGEFs activated by
diacylglycerol (DAG) and phorbol ester. All RasGRPs
have a common domain architecture, with an amino-
terminal REM and catalytic CDC25 domain followed
by a pair of Ca2+-binding atypical EF hands and a C1
domain that binds DAG and phorbol ester (Figure 2A).
However, the different isoforms exhibit variations in
GTPase specificity, expression distribution, subcellu-
lar location, and signal regulation.
RasGRPs have overlapping, but not identical,
GTPase specificity and activate the Ras, R-Ras, and/or
Rap family of proteins, with RasGRP3 exhibiting the
broadest GTPase substrate specificity (Table 1). Differ-
ences in their ability to activate specific Ras isoforms
are also seen: GRP1, 3, and 4 have been reported to
activate H-Ras, whereas RasGRP2 did not activate H-
Ras, but did activate K- and N-Ras [23–27]. This differ-
ential activation of Ras isoforms is most likely due to
the localization of different Ras isoforms to distinct
membrane microdomains [28]. The observations that
Ca2+ upregulation stimulated the RapGEF and inhibited
the RasGEF activity of RasGRP2, whereas DAG kinase
Review
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Table 1. Regulators and effectors of Ras.
Protein Other activities Substrates
GEFs
Sos1 RacGEF H-Ras, N-Ras, K-Ras, R-Ras2, R-Ras3, Rac1; not R-Ras
Sos2 RacGEF H-Ras
Ras-GRF1 RacGEF H-Ras, K-Ras1, N-Ras1, R-Ras, R-Ras2, R-Ras3, Rac1; not K-Ras1, N-Ras1, 
Rap1
Ras-GRF2 RacGEF H-Ras, Rac1; not R-Ras
RasGRP1 (CalDAG-GEFII) DAG-, Ca2+-binding H-Ras, N-Ras, R-Ras, R-Ras2, R-Ras3; not Rap1A
RasGRP2 (CalDAG-GEFI) DAG-, Ca2+-binding N-Ras, K-Ras, R-Ras, R-Ras2, Rap1A, Rap2A; not H-Ras
RasGRP3 (CalDAG-GEFIII) DAG-, Ca2+-binding H-Ras, R-Ras, R-Ras2, R-Ras3, Rap1A, Rap2B
RasGRP4 DAG-, Ca2+-binding H-Ras
GAPs
p120 RasGAP p190 RhoGAP-binding H-Ras, N-Ras, R-Ras, R-Ras2, R-Ras3, Rab5; not Rap proteins
Neurofibromin H-Ras, K-Ras, N-Ras, R-Ras, R-Ras2, R-Ras3; not Rap1A
SynGAP H-Ras
GAP1IP4BP
(R-Ras GAP) Inositol 1,3,4,5- H-Ras, R-Ras, R-Ras2, Rap1A
tetrakisphosphate-binding
GAP1m PIP3-binding; Ga12 H-Ras, R-Ras, R-Ras2, R-Ras3; not Rap1A
RASAL1 Ca2+-binding H-Ras
CAPRI Ca2+-binding H-Ras
DAB2IP (DIP1/2) DOC-2/DAB2-binding H-Ras, K-Ras, R-Ras, R-Ras2; not Rap1A
Effectors
Raf-1 Serine/threonine kinase MEK1 and MEK2 tyrosine/threonine kinases
A-Raf Serine/threonine kinase MEK1 and MEK2 tyrosine/threonine kinases
B-Raf Serine/threonine kinase MEK1 and MEK2 tyrosine/threonine kinases
p110 alpha Phosphoinositide 3-kinase Phosphatidylinositol (4,5)-biphosphate
p110 beta Phosphoinositide 3-kinase Phosphatidylinositol (4,5)-biphosphate
p110 delta Phosphoinositide 3-kinase Phosphatidylinositol (4,5)-biphosphate
p110 gamma Phosphoinositide 3-kinase Phosphatidylinositol (4,5)-biphosphate
RalGDS RalGEF RalA and RalB small GTPases
RGL RalGEF RalA and RalB small GTPases
RGL2 (Rlf) RalGEF RalA and RalB small GTPases
RGL3 RalGEF RalA and RalB small GTPases
Tiam1 RacGEF Rac1, Rac2, Rac3 small GTPases
PLC epsilon RasGEF Rap1A, Ras1
RIN1 Rab5 GEF; Abl-binding Rab5A
RIN2 (RIN1); amphiphysin II-
RIN3 binding (RIN2, RIN3)
AF-6 Scaffold/adaptor Profilin
RasIP1 (Rain)
RASSF1 MST1
RASSF2 MST1
RASSF4 MST1
RASSF5 (Nore1) MST1
IMP E3 ubiquitin ligase Kinase suppressor of Ras (KSR)
1Conflicting reports for substrate specificity have been made.
iota inhibited RapGEF and activated RasGEF activity of
RasGRP3 provides evidence for temporal regulation of
specific GTPase activation [24,29]. Furthermore, the
distinct subcellular locations of Ras and Rap GTPases
also argue that activation of different subcellular pools
of a RasGRP can dictate selective activation of only a
subset of its substrates.
Like Sos, RasGRP activation requires association
with membranes. Unlike Sos, however, RasGRP is
recruited via membrane-associated DAG binding to its
protein kinase C (PKC)-like, cysteine-rich C1 domain
[23,24,30–32]. The phospholipase C (PLC) family of
enzymes hydrolyze PIP2 and produce the second
messengers DAG and inositol 1,4,5-trisphosphate
(IP3). Hence, PLC-mediated DAG production provides
a mechanism for RasGRP activation, for example by
activation of PLCβ-linked G-protein coupled receptors
or PLCγ-linked receptor tyrosine kinases. In contrast
to the significant DAG-mediated activation of
RasGRP1, RasGRP3, and RasGRP4 [23,30–32],
RasGRP2 exhibits low-affinity binding and low
responsiveness to DAG. Instead, it may rely on actin
dynamics for membrane recruitment [33].
Two splice variants of RasGRP2 have been
described (Figure 2A) and their different GEF activities
suggest that the spatial and temporal location of
RasGRPs may also influence their GTPase specificity.
The smaller, 609 residue RasGRP2 isoform 2 (also
called CalDAG-GEFI) was found to activate Rap1A but
not H-Ras [23]. In contrast, the longer RasGRP2
isoform 1 variant contains an additional 62 amino-ter-
minal residues that include signal sequences for
myristoylation and palmitoylation [24]. This lipid-mod-
ified form of RasGRP2 is constitutively membrane-
associated, and causes activation of Rap1 as well as
K-Ras and N-Ras, but not H-Ras. Similarly, although
not seen with short-term stimulation, long-term expo-
sure to phorbol ester resulted in RasGRP2 isoform 2
association with the plasma membrane, and a corre-
sponding activation of Ras. Finally, in contrast to the
shorter RasGRP2 protein, the longer variant was inhib-
ited, rather than stimulated, by Ca2+ upregulation. The
important influence of differences in subcellular local-
ization is also emphasized by the observation that
RasGRP1 (and RasGRP3), but not RasGRP2
(isoform 2), is localized to Golgi and preferentially acti-
vates Golgi-localized Ras [34]. Recent studies from a
number of labs showed that H-Ras and N-Ras are
activated and can signal from not only plasma mem-
brane but also from endomembranes (reviewed in
[35]). The presence of a particular RasGRP isoform on
the Golgi may promote selective activation of Ras in
that location and lead to a biological outcome distinct
from the plasma-membrane-localized Ras [36].
The importance of the EF hands in RasGRP is
demonstrated by Ca2+ ionophore treatment and acti-
vation of RasGRP activity [23,24]. Unlike activation of
Ras by RasGRP1, the exchange activity of RasGRP2
toward N-Ras was inhibited by Ca2+ [24]. The role of
Ca2+ in activation of RasGRP3 is less clear [32]:
instead, RasGRP3 exchange activity toward Ras is
regulated by DAG-mediated activation of PKC and
direct phosphorylation of RasGRP3, together with
DAG-mediated translocation of RasGRP3 to the
plasma membrane [37–39]. PKC-mediated phospho-
rylation may also similarly potentiate the RasGEF
activity of RasGRP1, but not that of RasGRP4.
RasGEF Isoform Differences and Development
In addition to their distinct mechanisms of regulation,
the dissimilar distributions of expression and conse-
quences of loss of function on mouse development
further distinguish the biological roles of the different
RasGEF isoforms. For example, Sos1, but not Sos2,
gene expression is essential for intrauterine develop-
ment, with homozygous null mice dying mid-gestation
[40,41]. On the molecular level, Sos1 is involved in both
short-term and long-term activation of Ras and the Erk
MAP kinase pathways downstream of the EGFR,
whereas Sos2 binds less efficiently to the EGFR and is
involved in relaying short-term signals downstream of
the EGFR in vivo [41]. The greater biological importance
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Figure 3. Regulation of Sos1 and activation of
Ras and Rac.
As described in the text, both receptor tyrosine
kinase and G-protein coupled receptor induced
signaling pathways regulate Sos1-mediated
activation of Ras or Rac.
Eps8
Abi-1 Grb2
RasRac
Abl
R
TK
PI3K
CDC25PHDH REM
Sos1
PXXP
PIP2PIP3
?
PYK2
Src
Gαq
Ca2+
H2A
Current Biology
of Sos1 may also be due, in part, to the greater protein
stability of Sos1, since only Sos2 and not Sos1 was
found to be degraded by a ubiquitin-dependent
process [42].
Similar expression and functional differences are
seen with other RasGEFs. In mammals, Ras-GRF1 is
expressed at high levels in the brain (mainly in the
hippocampus), with traces found in other tissues
[43–45]. Ras-GRF2 expression is also high in the brain,
but exhibits a less restricted expression distribution
[16,46]. Both Ras-GRF1 and Ras-GRF2 are expressed
abundantly in the neurons of the adult central nervous
system, but not in surrounding glial cells [47].
Although Ras-GRF-mediated signaling is dispens-
able for mouse development, normal neurological
function and growth are compromised with the loss of
Ras-GRF function. Mice lacking grf1 and grf2 are
viable and fertile [45,48,49] with grf1-deficient mice
exhibiting some defects in long-term memory consol-
idation and reduced growth hormone levels. Unlike
grf1-deficient mice, grf2-deficient mice are not
reduced in size [45]. Interestingly, deletion of grf2 in a
grf1 null background does not lead to any change in
size compared to the grf1 null animals, suggesting a
lack of functional overlap between Ras-GRF1 and
Ras-GRF2 for this phenotype [45]. In contrast, in the
brain both Ras-GRF1 and Ras-GRF2 play a protective
role in neurodegeneration associated with stroke, and
suppression of NMDAR-mediated Erk activation
required the loss of both Ras-GRF genes, suggesting
redundant functions in this signaling pathway [17].
The different RasGRP mRNA transcripts (with the
exception of RasGRP4) are found in the same tissues,
in particular hematopoietic tissues and the brain, but
RasGRPs show distinct expression distribution within
these tissues. For example, RasGRP1 expression was
seen primarily in T cells, RasGRP2 expression in neu-
trophils and platelets, and RasGRP3 expression in B
cells [50–52]. In contrast, RasGRP4 expression was
seen in mast cells, but not lymphoid or brain cells
[26,27]. This pattern of expression is reflected in the
distinct phenotypes of the particular RasGRP-defi-
cient mice. Rasgrp1-deficient animals were viable, but
showed impaired T-cell, but not B-cell, development
and impaired T-cell receptor stimulated activation of
Ras and proliferation [53]. In contrast, platelets from
Rasgrp2-deficient mice were severely compromised in
integrin-dependent signaling and aggregation, and
these animals showed an increased tendency for
bleeding [51]. Finally, loss of function of either
Rasgrp1 or Rasgrp2 or Rasgrp3 did not impair mouse
development [54], suggesting functional redundancy
within the family, or with other RasGEFs. Future
studies with double-deficient mice may be able to
clarify this subject.
RasGAPs: The Forgotten Regulators?
RasGAPs have a common ~250 amino acid RasGAP
catalytic domain, but otherwise show essentially no
sequence similarity or domain architecture in the
sequences that flank this RasGAP domain (Figure 2B)
[55]. GAPs accelerate the very slow intrinsic GTP
hydrolysis activity of Ras by several orders of magni-
tude. In contrast to RasGEFs, there is considerably
less information regarding the mechanisms that regu-
late RasGAP activity and, instead, it has been gener-
ally believed that their activities are constitutive.
Hence, while the involvement of RasGEFs in extracel-
lular signal regulation of Ras activity has been well-
studied and well-characterized, RasGAPs have been
relegated to secondary roles as signal-mediated Ras
regulators. While there is limited evidence for signal
transduction-mediated regulation of RasGAP activity,
their best-characterized involvement in Ras regulation
arises from the occurrence of RasGAP-insensitive
mutants of Ras or the loss of RasGAP expression in
human cancers.
p120 RasGAP
p120 RasGAP was the first GAP to be discovered and
provided an important biochemical explanation for why
mis-sense mutations at Ras residues G12 or Q61 result
in constitutively activated, highly transforming proteins
[55]. These tumor-associated mutant Ras proteins are
found in 30% of all human cancers, and are insensitive
to the action of GAPs and hence are persistently GTP-
bound. Less clear is the importance of p120 RasGAP
in the regulation of normal Ras function.
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Figure 4. Ras-GRF1 regulates GTPase
activation and effector utilization. 
NMDAR- or G-protein-coupled receptor-
mediated upregulation of cytoplasmic
Ca2+ promotes Ca2+-activated calmodulin
(CaM) association with the IQ motif to
promote RasGEF activation. As described
in the text, RasGRF1 also serves as a
scaffold that facilitates Rac activation and
Rac-mediated activation of specific
downstream effector function.
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Neurofibromin
Neurofibromin is the gene product of NF1, a tumor
suppressor gene lost in the autosomal dominantly
inherited disorder neurofibromatosis type 1 (NF1) [56].
Affected individuals are prone to the development of
benign and malignant tumors. Loss of neurofibromin
expression in NF1-associated tumors or Nf1-deficient
mouse cells is associated with elevated Ras activity
and signaling, and increased cell proliferation. Tumor-
associated Ras mutant proteins are also insensitive to
neurofibromin-mediated inhibition.
As with p120 RasGAP, the evidence for regulation
of neurofibromin-mediated inhibition of normal Ras
function is limited. Growth factor stimulation of NIH
3T3 mouse fibroblasts was found to cause a rapid
and transient downregulation of neurofibromin
protein levels that was dependent on ubiquitin-medi-
ated proteolysis [57]: levels were low or undetectable
after 5 min, but restored by 30 min and correlated
with changes in Ras–GTP levels. In contrast, Nf1-defi-
cient mouse fibroblasts showed prolonged Ras acti-
vation, supporting a role for neurofibromin in
attenuating Ras activation after growth factor stimu-
lation.
Other RasGAPs
Additional RasGAPs have been identified and mech-
anisms for their regulation have been described.
GAP1IP4BP and Gap1m are founding members of a
family of four RasGAPs that have a common domain
architecture yet display distinct mechanisms of reg-
ulation. Their RasGAP domains are flanked by
amino-terminal tandem Ca2+-dependent lipid-binding
C2 domains and a carboxy-terminal PH domain
which contains a Bruton’s tyrosine kinase (Btk) motif
(Figure 2B).
Despite their similar domain architecture, RasGAP
family members exhibit different modes of regulation
and association with the plasma membrane.
GAP1IP4BP has a constitutive PH-domain-dependent
plasma membrane association [58], possibly mediated
by PIP2 binding [59], and its Ras GAP activity may be
regulated by inositol 1,3,4,5-tetrakisphosphate [60]. In
contrast, GAP1m was not found at the plasma mem-
brane, and instead, showed a distinct, perinuclear and
cytoplasmic localization. However, EGF activation of
PI3K and production of PIP3 promoted a PH-domain-
dependent translocation of GAP1m to the plasma
membrane [61]. Surprisingly, plasma membrane asso-
ciation did not seem to activate the RasGAP function
of GAP1m. By contrast, the third member of this
family, CAPRI, is normally cytosolic and inactive, and
a G-linked receptor-stimulated increase in Ca2+ levels
causes CAPRI to undergo a rapid, C2-domain-depen-
dent association with the plasma membrane that acti-
vates the RasGAP activity of CAPRI, leading to
reduced Ras activity [62]. RASAL, the fourth member
of the family, also undergoes Ca2+-stimulated plasma
membrane association but, additionally, oscillates
between the plasma membrane and the cytosol in
synchrony with simultaneously measured repetitive
Ca2+ spikes [63]. Hence, Ca2+ regulation controls the
activities of RasGAPs as well as RasGEFs.
SynGAP, which is expressed primarily in the brain
and localizes to glutamatergic synapses, was
observed to be positively regulated by phosphoryla-
tion by Ca2+/calmodulin-dependent kinase II [64].
Finally, the human DOC-2/DAB2 interactive protein
(DAB2IP) has been shown to exhibit RasGAP activity
in vitro and its gene expression is reduced by DNA
methylation in some cancers [65].
Ras Effectors as GEFs and Activators of Ras Family
Small GTPases
Although Raf serine/threonine kinases are the most
well-understood effectors of Ras-mediated activation
of the Erk MAPK cascade, a functionally diverse range
of Ras effector proteins has been identified that also
facilitate Ras function [66]. Here we focus on the Ras
effectors that serve as GEFs and activators of Ras
family proteins (Figure 5).
RalGEFs Link Ras and Ral
A subset of RalGEFs link activated Ras to activation
of the RalA and RalB small GTPases [67,68]. The
RalGEF family of proteins (RalGDS, RGL, RGL2/Rlf,
and RGL3) can interact with activated Ras–GTP
through their Ras association (RA) domains. RalGEFs
may serve as effectors for other Ras family proteins
(such as R-Ras proteins and Rit) [69]. Similar to
RasGEFs, RalGEFs possess a tandem REM–CDC25
homology domain topology (Figure 2C), but RalGEFs
specifically activate Ral, and not Ras, Rap, or R-Ras
proteins (Table 1).
Initial studies in rodent fibroblasts established a rel-
atively minor role for RalGEFs in Ras-mediated trans-
formation [66,68], although recent studies have found
that RalGEFs are important effectors of Ras transfor-
mation of human cells and are necessary and sufficient
to promote Ras-mediated transformation [70]. These
observations suggest species-specific differences in
Ras utilization of effectors. Despite the fact that there
is limited evidence that RalGEFs have functions other
than activation of Ral GTPases, the important role of
RalGEF catalytic activity in transformation is supported
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Figure 5. Ras effectors function as GEFs to diversify Ras sig-
naling and engage other GTPase cascades.
As described in the text, some Ras effectors serve as GEFs for
other members of the Ras GTPase superfamily.
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by the critical contribution of Ral GTPase function in
human cancer cell proliferation and survival [71].
Ral GTPases have been implicated as regulators of
a variety of cellular processes (Figure 5). These
include the regulation of endocytosis, exocytosis,
actin cytoskeletal organization, cell migration, and
gene expression. As with Ras and other Ras family
proteins, Ral GTPases interact with multiple, function-
ally distinct downstream effectors to mediate their
divergent biological functions, as discussed in detail
in recent reviews [67,68].
As mentioned above, despite their strong sequence
and biochemical similarities, distinct biological activi-
ties for RalA and RalB have been described. Using
RNA interference approaches to selectively suppress
RalA or RalB expression, White and colleagues deter-
mined that RalB served an important role in cell sur-
vival for human tumor cells, but not normal cells [71].
In contrast, RalA was important for the anchorage-
independent growth of cancer cells. Furthermore,
RalA and RalB exhibited antagonistic roles in cell sur-
vival, because the concurrent loss of RalA expression
in RalB-deficient cells prevented the apoptotic
response that usually arises from a loss of RalB
expression. Finally, RalA but not RalB activation was
found to be important for Ras-mediated transforma-
tion of human embryonic kidney cells, and for the
growth of pancreatic and other human cancer cells
carrying mutations in Ras [72]. These functional differ-
ences between the Ral isoforms may be due, in part,
to their differential ability to interact with effectors
and, perhaps more importantly, to their distinct sub-
cellular localizations [73].
RIN Proteins Are a Direct Link between Ras and
Rab Pathways
RIN1 is another Ras effector [74,75] that functions as
a small GTPase GEF and may facilitate Ras regulation
of endocytosis [76] (Figure 5). RIN1 associates with
activated Ras through a carboxy-terminal RA domain
(Figure 2C). RIN1 also contains a distinct Vps9p
domain, a catalytic domain with GEF activity toward
Rab5/Vps21p-like proteins [77]. Consistent with its
role as a Rab5 GEF, RIN1 binds exclusively to a GDP-
bound form of Rab5 and promotes dissociation of
GDP from Rab5 proteins in vitro. Furthermore, acti-
vated Ras potentiates the Rab5 GEF activity of RIN1.
Rab5 is a member of the Rab family of GTPases, the
largest branch of the Ras superfamily (with 63 human
members), which regulates intracellular vesicular
transport [3]. Rab5 regulates the trafficking of plasma-
membrane-localized signaling molecules in early
steps of endocytosis — binding and fusion of newly
budded vesicles with early endosomes [78]. RIN1 pro-
motes EGF-induced receptor endocytosis and this
RIN1-mediated endocytosis is enhanced by expres-
sion of activated Ras and completely blocked by a
dominant-negative Rab5 mutant [77]. Thus, RIN1 is an
important, if not essential, link between Ras and Rab5
in endocytosis.
Other RIN family members include RIN2 and RIN3
[79,80]. RIN2 and RIN3 contain an RA domain and
bind to a panel of Ras family members in vivo [69]
and, like RIN1, possess catalytically active Rab5 GEF
domains. However, unlike RIN1, which preferentially
associates with Rab5–GDP, RIN2 and RIN3 also bind
to Rab5–GTP and thus may serve as both Rab5 acti-
vators and downstream effectors. Furthermore, it is
not clear whether Ras binding activates the Rab5 GEF
activity of RIN2 and RIN3. Finally, although all three
RIN isoforms are expressed widely, differences in
expression distribution are seen, as well as differ-
ences in subcellular location [80]. RIN3 and RIN2 are
localized to endocytic vesicles, whereas RIN1 exhibits
a cytoplasmic distribution. Thus, these related pro-
teins may not serve functionally redundant roles.
Tiam1 Facilitates Additional Links between Ras and
Rac
Tiam1 contains a DH–PH domain cluster and is a Rac-
specific GEF. In addition to the DH–PH cluster, Tiam1
contains an RBD (Ras-binding) domain, similar to the
RBD domain found in the Ras effector Raf (Figure 6).
A study by Lambert et al. [81] showed that Ras binds
to and stimulates Tiam1 RacGEF activity, suggesting
that Tiam1 serves as a link between Ras and Rac
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Figure 6. Activated Ras–GTP association
with the RBD promotes Tiam1 activation
of Rac. 
Tiam1 is activated by upstream stimuli
including PI3K, Src, NMDAR-stimulated
Ca2+ influx, and receptor tyrosine kinase
activation. Similar to Ras-GRF1, the PH
domain of Tiam1, together with the adja-
cent coiled-coil (CC) and Ex sequences
(which promote Tiam1 membrane associ-
ation; also called the TSS domain), inter-
act with JIP2/IB2 to facilitate Rac
activation of the MLK3–MKK3–p38 MAPK
cascade (not shown), with spinophilin to
promote Rac activation of p70 S6 kinase
[98], and with IRSp53 to promote Rac-
mediated lamellipodia formation (not
shown).
RBD PDZPH PHDHCC
Rac
Ras
Spinophilin
 S6K
Tiam1
Src
?
PI3K
PIP2 PIP3
Rap
Gαi RT
K
Ca2+
?
?
?
Ex
Current Biology
(Figure 6). The importance of Tiam1 as a direct link
between Ras and Rac has been revealed by studies in
Tiam1-deficient mice [82]. Cells from these mice
showed impaired Ras activation of Rac and the mice
were resistant to Ras-induced skin tumorigenesis.
Tiam1 also facilitates Rac activation downstream of
Rap1A [83]. Cell spreading initiated by activated
Rap1A was associated with and dependent on Rac
activation. This mechanism involved activated Rap1
association with Tiam1, but with the DH–PH domains,
rather than the RBD (Figure 6), recruiting Tiam1 to the
periphery of spreading cells. Interestingly, constitutive
activation of Tiam1 alone was not sufficient to
promote spreading and instead required coordinate
Rap1 activation. The ability of activated Rap1 to cause
relocalization of Tiam1 to membrane protrusions at
the cell periphery suggests a mechanism where Rap1
promotes cell spreading by localizing specific
RacGEFs to sites of active lamellipodial extension.
Rap1 therefore regulates a spatially distinct pattern of
Rac activation that may influence the effector func-
tions that are in turn regulated by Rac [84].
PLCε Is a Point of Convergence for Ras, Rho and
Heterotrimeric G Protein Signaling
PLCε is the latest addition to the human PLC family
and has the same phospholipase catalytic activity as
all PLCs [85]. All members contain catalytic X and Y
domains and a Ca2+-dependent lipid-binding C2
domain [86,87]. PLCε is a distinct member in that, in
addition to these domains, it contains an amino-ter-
minal RasGEF/CDC25 homology domain, as well as
tandem carboxy-terminal RA domains (Figure 2C).
The lipase activity of PLCε is activated through its
RA domains by a variety of signaling molecules
including activated H-Ras [88], TC21/R-Ras2 [89],
Rap1A, and Rap2B [90]. In contrast, other small
GTPases (RalA, RhoA, and Rac1), as well as het-
erotrimeric Gα12 and Gα13 subunits, or Gβγ, stimulate
PLCε lipase activity via RA-domain-independent
mechanisms [91–93] (Figure 7). PLCε has also been
shown to be activated by various receptor tyrosine
kinase and G-protein-coupled receptor agonists by
distinct pathways [93]. PDGF and EGF stimulate PLCε,
presumably through Ras activation, since this activity
is dependent on the second RA domain of PLCε
[90,93]. In contrast, the G-protein-coupled receptor
agonists lysophosphatidic acid, sphingosine 1-phos-
phate and thrombin can activate PLCε in a partially
RA-domain-independent manner. G-protein-coupled
receptor activation of PLCε may proceed through
Gα12/Gα13-mediated activation of RhoA [85,93] or
Gαs-stimulated production of cAMP and activation of
the RapGEF Epac (Figure 7). How these stimuli influ-
ence the catalytic activity of the CDC25 homology
domain, which has been reported to act as a Rap-spe-
cific GEF [94], has not been determined.
PDGF induces biphasic activation of PLCε: initial
rapid activation was mediated by Ras, whereas per-
sistent activation was stimulated by Rap1 [90]. In
hematopoietic cells, signaling through PLCε is
required for proliferation and protection from apopto-
sis [90,95]. Recently, PLCε has been shown to play a
crucial role in a chemical carcinogen-induced, H-Ras
mutation-mediated skin tumor development and pro-
gression [96]. Plcε-deficient mice showed a significant
delay in the time of tumor appearance, in the fre-
quency of tumor formation, and in malignant progres-
sion.
GEFs Function as Scaffolds that Influence the
Effector Activation of Their GTPase Substrates
An emerging theme in GEF function is an ability of the
GEF to additionally influence the downstream effec-
tors of their GTPase targets by functioning as scaf-
folds. For example, a recent study found that
Ras-GRF1 associated with the JIP2/IB2 protein, via
PH–CC–IQ sequences in Ras-GRF1. This association
led to an increase in Rac-dependent activation of the
p38 stress/cytokine-activated MAPK cascade [97]
(Figure 4). JIP2/IB2 is a scaffold for the p38 MAPK
cascade as it brings together the Rac effector MLK3,
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Figure 7. GTPase activation of PLCε.
Activated Ras, Rap1, Rap2, and R-Ras
proteins promote PLCε lipase activity by
interaction with the RA domains [88,90],
whereas activated RhoA, Ral, and Gα and
Gβγ subunits activate PLCε via RA-
domain-independent mechanisms that
remain to be defined.
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the MAPK kinase MKK3, and p38. Similarly, the anal-
ogous PH–CC–Ex region of Tiam1 can bind to
JIP2/IB2 [97]. Interestingly, although this scaffolding
complex is associated with activation of the related
JNK MAPK, JIP2/IB2 facilitated Ras-GRF1- and
Tiam1-induced activation of p38 instead.
The same regions of Tiam1 and Ras-GRF1 also
interact with spinophilin (also called neurabin II), a
scaffold that binds to another Rac effector, p70 S6
kinase. This association promoted Tiam1 localization
to the plasma membrane, and enhanced Rac-depen-
dent activation of p70 S6 kinase [98]. Finally, the
Tiam1 PH–CC–Ex region has been found to bind yet
another Rac and Cdc42 effector, IRSp53 [99]. In this
case, Tiam1 served as a scaffold bringing together
IRSp53, activated Rac, and WAVE2, to facilitate Rac-
mediated changes in actin organization.
Conclusions and Perspective
Our understanding of Ras signal transduction contin-
ues to undergo remarkable evolution. We now are
aware that the three Ras proteins are functionally dis-
tinct, due in part to associations with distinct
microdomains of the plasma membrane, as well as
with endomembrane compartments. The continuing
identification of additional regulators and effectors
adds to the complexities of Ras signaling. How these
components facilitate differences in the spatio-tem-
poral activity of Ras and how they interconnect Ras
with other signaling networks will still need to be
addressed. Ras protein signaling networks also facili-
tate functional interactions with many of its relatives in
the Ras superfamily, in particular Rho family GTPases,
with GEFs being the key mediators of these links. The
multiple RasGEFs allow diverse extracellular stimuli to
promote Ras activation, and additionally serve as
points of signaling convergence and divergence. An
emerging concept is that distinct RasGEFs determine
the membrane compartments in which Ras becomes
activated as well as the effectors or downstream path-
ways that are utilized [35]. The mechanisms by which
GEFs themselves are regulated are diverse and
complex. Furthermore, cell-type-specific differences
in these regulatory mechanisms are certain to be
found. Despite these remarkable advances in the
delineation of Ras-mediated signaling, there is no
doubt that future studies will reveal further intricacies
of Ras signaling networks, with many more players
and inter-relationships yet to be discovered.
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